STOCKWATCH: BGI-Shenzhen and Illumina in tug of war over Complete Genomics
This article was originally published in Clinica
Executive Summary
In the past few days it has become clear that the original $118 million bid for Californian genome sequencing firm Complete Genomics by China's BGI-Shenzhen was trumped by a $124 million bid from another US sequencing technology company Illumina. China's BGI-Shenzhen agreed to buy Complete Genomics in September (www.clinica.co.uk, 18 September 2012); the latter has been looking for a buyer since early June.